CFF, C. (2016). Health Canada alerta pacientes sobre os riscos do CRESTOR® (rosuvastatina). Farmacoterapêutica, 10(04), 6. Recuperado de https://revistas.cff.org.br/farmacoterapeutica/article/view/1530